Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Sci Rep ; 10(1): 19038, 2020 11 04.
Artigo em Inglês | MEDLINE | ID: mdl-33149246

RESUMO

Dietary phosphate intake is closely correlated with protein intake. However, the effects of the latter on phosphate-induced organ injuries remain uncertain. Herein, we investigated the effects of low (10.8%), moderate (23.0%), and high (35.2%) dietary casein and egg albumin administration on phosphate-induced organ injuries in rats. The moderate and high casein levels suppressed renal tubulointerstitial fibrosis and maintained mitochondrial integrity in the kidney. The serum creatinine levels were suppressed only in the high casein group. Phosphate-induced muscle weakness was also ameliorated by high dietary casein. The urinary and fecal phosphate levels in the early experiment stage showed that dietary casein did not affect phosphate absorption from the intestine. High dietary egg albumin showed similar kidney protective effects, while the egg albumin effects on muscle weakness were only marginally significant. As the plasma branched-chain amino acid levels were elevated in casein- and egg albumin-fed rats, we analyzed their effects. Dietary supplementation of 10% branched-chain amino acids suppressed phosphate-induced kidney injury and muscle weakness. Although dietary protein restriction is recommended in cases of chronic kidney disease, our findings indicate that the dietary casein, egg albumin, and branched-chain amino acid effects might be reconsidered in the era of a phosphate-enriched diet.


Assuntos
Aminoácidos de Cadeia Ramificada/administração & dosagem , Caseínas/administração & dosagem , Nefrite Intersticial/etiologia , Nefrite Intersticial/patologia , Ovalbumina/administração & dosagem , Fosfatos/efeitos adversos , Animais , Biópsia , Modelos Animais de Doenças , Suscetibilidade a Doenças , Imuno-Histoquímica , Debilidade Muscular/dietoterapia , Debilidade Muscular/etiologia , Debilidade Muscular/patologia , Nefrite Intersticial/dietoterapia , Ratos
2.
Intern Med ; 57(24): 3603-3610, 2018 Dec 15.
Artigo em Inglês | MEDLINE | ID: mdl-30101934

RESUMO

We present a case of Dent disease caused by a novel intronic mutation, 1348-1G>A, of the chloride voltage-gated channel 5 (CLCN5) gene. Cultured proximal tubule cells obtained from the patient showed impaired acidification of the endosome and/or lysosome, indicating that the 1348-1G>A mutation was indeed the cause of Dent disease. Although the prevalence of osteomalacia in Dent disease is low in Japan, several factors-including poor medication adherence-caused severe osteomalacia in the current case. Oral supplementation with calcium and native/active vitamin D therapy, with careful attention to medication adherence, led to the improvement of the patient's bone status.


Assuntos
Canais de Cloreto/genética , Doença de Dent/genética , Osteomalacia/genética , Mutação Puntual , Adulto , Cálcio da Dieta/uso terapêutico , Doença de Dent/complicações , Doença de Dent/patologia , Suplementos Nutricionais , Humanos , Íntrons , Japão , Túbulos Renais Proximais/patologia , Masculino , Adesão à Medicação , Osteomalacia/tratamento farmacológico , Osteomalacia/etiologia , Osteomalacia/patologia , Vitamina D/uso terapêutico , Vitaminas/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA